Drug intelligence / Profile preview

unithiol

Development stage
Unknown
Lead developer
Heyl Pharma
Modality
Small Molecules
Administration
Intravenous, Intramuscular, Oral
01

Overview

Unithiol (sodium 2,3-dimercapto-1-propanesulfonate, DMPS) is a water-soluble dithiol chelating agent developed as an analogue of dimercaprol (BAL). It contains two vicinal sulfhydryl groups that exhibit high affinity for heavy metal cations, including mercury, arsenic, lead, and copper. By forming stable, non-toxic, water-soluble complexes (mercaptides), unithiol facilitates the mobilization of metals from tissues and their subsequent renal excretion. It is primarily indicated for the treatment of acute and chronic heavy metal poisoning and is being investigated for its efficacy in treating peripheral neuropathy associated with occupational metal exposure. It is widely used in clinical practice in China and Eastern Europe for occupational toxicology.

Brand names
DimavalUnithiolum
Other names
sodium 2,3-dimercapto-1-propanesulfonate2,3-dimercaptopropane-1-sulfonate sodiumsodium unithiolDMPS sodium
02

Targets

PB2 (Influenza PB2)CD2 (T-cell Surface Antigen CD2)

Beyond the preview

Go deeper on unithiol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on unithiol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call